PharmiWeb.com - Global Pharma News & Resources
24-Nov-2022

Platelet Rich Plasma Market exhibiting CAGR of 14.5% from 2023 to 2032, owing to a rising number of cosmetic surgeries | insightSLICE

The global Platelet Rich Plasma market size was estimated to be US$ 550 million in 2021 and is expected grow at a CAGR of 14.5% between 2023 to 2032.

For quick recovery from medical issues, platelet rich plasma has become a popular therapy option. Simple centrifugal separation of plasma from other blood components is used to create concentrated plasma from human blood.

The primary factors driving the growth of the global platelet rich plasma market are the rise in orthopaedic problems, the popularity of cosmetic surgery, and the expanding use of plasma therapy in emerging nations.

Access the sample report: https://www.insightslice.com/request-sample/312

According to information provided by the American Society of Plastic Surgeons, 17.7 million cosmetic treatments were carried out in the United States alone in 2018, an increase of 2.0% from the previous year.

The growth of these surgical procedures outside of the United States, particularly in Asia Pacific, is expected to present considerable potential for platelet-rich plasma during the projection period.

The key players of the Global Platelet Rich Plasma Market are:

Major players present in the global platelet rich plasma market include companies like Zimmer Biomet, Inc., AdiStem Ltd., Arthrex, Inc., Cesca Therapeutics, Inc., ISTO Biologics, Nuo Therapeutics, Exactech Inc., Harvest Technologies Corporation, Stryker Corporation, and DePuy Synthes.

For instance, Zimmer Biomet recorded revenues of US$ 7,933 million in 2018. According to the company’s business segment analysis, the Knees product category accounted for the majority of the company’s revenues in 2018, with the American market as the main revenue-producing region.

Additionally, the market shares of well-known businesses operating in the worldwide platelet rich plasma market would be calculated. For instance, the six core businesses of Zimmer Biome are Knees, Hips, S.E.T., Spine & CFM, Dental, and Others and these are specifically covered in this report.

The company’s S.E.T. business division contributed US$1,752 Million in revenue in 2018, and thus provides platelet-rich plasmas in the market.

Read more about the report inclusions: https://www.insightslice.com/platelet-rich-plasma-market

Factors and developments considered in this report:

The study also takes into account the major competitive factors, such as corporate strategies, product portfolios, key developments, SWOT analyses, and the emphasis on research and development among all the producers of platelet rich plasma and related goods.

Additionally, the market shares of well-known businesses operating in the worldwide platelet rich plasma market would be calculated. For instance, the six core businesses of Zimmer Biome are Knees, Hips, S.E.T., Spine & CFM, Dental, and Others and these are specifically covered in this report.

The company’s S.E.T. business division contributed US$1,752 Million in revenue in 2018, and thus provides platelet-rich plasmas in the market. The participants involved in the industry’s supply chain and value chain, as well as their contributions, will be considered in the study of the worldwide platelet rich plasma market.

All of the goods in the company’s platelet rich plasma business segment would be the main focus of the product portfolio.

Similarly to that, the subsection on the latest developments would concentrate on the company’s most recent activities, including strategic partnerships and alliances, mergers and acquisitions, the introduction of new products, and geographic coverage in the global platelet rich plasma market.

Related reports:

Global Thin Film Drugs Market: https://www.insightslice.com/thin-film-drugs-market

Global Intrauterine Devices Market: https://www.insightslice.com/intrauterine-devices-market

Global Platelet Rich Plasma Market Key Segments:

By Type

  • Pure Platelet Rich Plasma
  • Leucocyte Rich Platelet Rich Plasma
  • Others

By Application

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
    • Ulcer healing
      • Venous ulcers
      • Pyoderma gangrenous ulcers
      • Traumatic ulcers
      • Diabetic ulcers
      • Trophic ulcers
      • Vasculitic ulcers
      • Others
    • Others
  • Ophthalmic surgery
  • Neurosurgery
  • General Surgery
  • Others

By End Use

  • Hospitals
  • Clinics
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

The market has separated each area into the countries and sub-regions that make up that region. The size and forecast for each region, nation, and sub-region from 2023 to 2032 are provided in the platelet rich plasma market research.

Proceed to purchase: https://www.insightslice.com/buy-now/312

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.

Contact us:

Alex R

+1 707 736 6633

alex@insightslice.com

https://www.insightslice.com/

Linkedin | Twitter

Editor Details

Last Updated: 24-Nov-2022